CG Oncology Balance Sheet Health
Financial Health criteria checks 5/6
CG Oncology has a total shareholder equity of $568.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $579.1M and $10.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$566.51m |
Equity | US$568.94m |
Total liabilities | US$10.17m |
Total assets | US$579.11m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: CGON's short term assets ($578.6M) exceed its short term liabilities ($10.0M).
Long Term Liabilities: CGON's short term assets ($578.6M) exceed its long term liabilities ($184.0K).
Debt to Equity History and Analysis
Debt Level: CGON is debt free.
Reducing Debt: CGON had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CGON has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if CGON has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.